K-Ras and Beyond Josep Tabernero, MD Vall d’Hebron University Hospital Barcelona, Spain.
Impact on Quality of Life of Adding Cetuximab to Irinotecan in Patients Who Have Failed Prior Oxaliplatin-Based Therapy: Results From the EPIC Trial Cathy.
